James Investment Research’s Ares Commercial Real Estate ACRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-57,960
Closed -$690K – 483
2020
Q4
$690K Hold
57,960
– – 0.06% 180
2020
Q3
$530K Hold
57,960
– – 0.05% 194
2020
Q2
$529K Buy
57,960
+4,415
+8% +$34.4K 0.05% 191
2020
Q1
$374K Hold
53,545
– – 0.04% 199
2019
Q4
$848K Buy
53,545
+70
+0.1% +$1.08K 0.06% 198
2019
Q3
$814K Buy
53,475
+3,160
+6% +$48.2K 0.06% 194
2019
Q2
$748K Buy
50,315
+8,625
+21% +$130K 0.05% 204
2019
Q1
$633K Buy
41,690
+1,475
+4% +$21.5K 0.04% 419
2018
Q4
$524K Buy
40,215
+3,885
+11% +$54.3K 0.03% 455
2018
Q3
$508K Buy
36,330
+2,990
+9% +$42.4K 0.02% 516
2018
Q2
$460K Buy
33,340
+90
+0.3% +$1.19K 0.02% 527
2018
Q1
$411K Buy
+33,250
New +$419K 0.02% 528
2017
Q1
– Sell
-81,650
Closed -$1.12M – 645
2016
Q4
$1.12M Buy
81,650
+17,050
+26% +$227K 0.03% 262
2016
Q3
$814K Buy
64,600
+9,670
+18% +$122K 0.02% 265
2016
Q2
$675K Buy
+54,930
New +$648K 0.02% 240

Other funds holding ACRE

James Investment Research's ACRE Position: Q1 2021 in Review

James Investment Research sold out of Ares Commercial Real Estate (ACRE) in Q1 2021, closing a stake of 57,960 shares — an estimated $690K sold.

James Investment Research first reported a position in ACRE in Q2 2016 and held it in 15 quarters. The position peaked at $1.12M in Q4 2016. 133 funds tracked by Wall St. Rank hold ACRE as of Q1 2021.

  • James Investment Research reported no remaining Ares Commercial Real Estate position as of Q1 2021 after selling out during the quarter.
  • James Investment Research sold 57,960 Ares Commercial Real Estate shares in Q1 2021, an estimated $690K.
  • James Investment Research first reported a position in Ares Commercial Real Estate in Q2 2016 and held it in 15 quarters.
  • James Investment Research's Ares Commercial Real Estate position peaked at $1.12M in Q4 2016.
  • 133 funds tracked by Wall St. Rank held Ares Commercial Real Estate as of Q1 2021.

Based on James Investment Research's 13F filing for Q1 2021, filed 22 Apr 2021.